gabexate has been researched along with Purpura, Thrombocytopenic in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Purpura, Thrombocytopenic: Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, M | 1 |
| Wakabayashi, Y | 1 |
| Koike, M | 1 |
| Saito, K | 1 |
| Osawa, H | 1 |
| Ishiyama, T | 1 |
| Sugimoto, M | 1 |
| Hirose, S | 1 |
1 other study available for gabexate and Purpura, Thrombocytopenic
| Article | Year |
|---|---|
[Gabexate mesilate induced remarkable transient reversal of thrombocytopenia in a ITP patient].
Topics: Female; Gabexate; Guanidines; Humans; Middle Aged; Platelet Count; Purpura, Thrombocytopenic; Remiss | 1991 |